Name: Industry Strategy on Drug Pricing: Making a Better Second Impression
Start: 2017-09-26T10:00:00-0400
End: 2017-09-26T10:50:00-0400

Back To Schedule

Industry Strategy on Drug Pricing: Making a Better Second Impression

Prepare biopharma companies to face tremendous pricing pressure from payers, scrutiny from politicians and controversy in the public sphere
Explore the ways pricing pressure effects innovation and R&D go/no-go decisions
Assess whether biopharma can count on the U.S. market to fund global R&D going forward and discuss possible alternatives

Moderators

Carly Helfand

Senior Editor, FIERCEMARKETS

Speakers

Kenneth Kaitin

Director, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT

Vice President, Global Health and Value, PFIZER INCORPORATED

Tuesday September 26, 2017 10:00am - 10:50am EDT
Renaissance Boston Waterfront 606 Congress St, Boston, MA 02210